A decrease in the content of LCAT and SCARB1 transcripts may be suggested to result in the diminished flow of cholesteryl ester to the liver, thus contributing to hyperalphalipoproteinemia [14]. This evidence concerns the gene LCAT and hyperalphalipoproteinemia.